Why the study?
Does TRIM18 regulate innate immunity and organ inflammation in viral-induced diseases?
Does TRIM18 regulate innate immunity and organ inflammation in viral-induced diseases?
TRIM18 is identified as a critical negative regulator of innate immunity in viral-induced diseases, presenting a potential therapeutic target for viral myocarditis.
Answers are grounded in this paper and cite their sources.
TRIM18 may be a therapeutic target in viral myocarditis; leaves open translation from animal models to human disease.
Our results indicate that TRIM18 serves as a negative regulator of viral myocarditis, lung inflammation and brain damage by downregulating innate immune activation induced by both RNA and DNA viruses. Our data reveal that TRIM18 is a critical regulator of innate immunity in viral induced diseases, thereby identifying a potential therapeutic target for treatment.
No takes yet. Share an insight, caveat, or question.
Fang et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: